These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 3905612)

  • 41. Monoclonal antibody against a genus-specific antigen of Chlamydia species: location of the epitope on chlamydial lipopolysaccharide.
    Caldwell HD; Hitchcock PJ
    Infect Immun; 1984 May; 44(2):306-14. PubMed ID: 6425219
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genetic transfer of Salmonella typhimurium and Escherichia coli lipopolysaccharide antigens to Escherichia coli K-12.
    Jones RT; Koeltzow DE; Stocker BA
    J Bacteriol; 1972 Sep; 111(3):758-70. PubMed ID: 4559827
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunoblot analysis of Salmonella typhi lipopolysaccharide (LPS) using typhoid sera.
    Vullo V; Mastroianni CM; Contini C; Cignarella L; Massetti AP; Falciano M; Paoletti F; Di Seri M
    Boll Ist Sieroter Milan; 1987; 66(2):130-3. PubMed ID: 2444235
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Failure of monoclonal antibodies to core glycolipid to bind intact smooth strains of Escherichia coli.
    Gigliotti F; Shenep JL
    J Infect Dis; 1985 Jun; 151(6):1005-11. PubMed ID: 2582064
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immune responses in chickens against lipopolysaccharide of Escherichia coli and Salmonella typhimurium.
    Sunwoo HH; Nakano T; Dixon WT; Sim JS
    Poult Sci; 1996 Mar; 75(3):342-5. PubMed ID: 8778727
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Production of serum antibodies that recognise epitopes located on the R3 region of Escherichia coli core lipopolysaccharides by patients infected with strains of enterohaemorrhagic E. coli.
    Chart H; Cheasty T; Willshaw GA
    J Med Microbiol; 2002 Dec; 51(12):1050-1054. PubMed ID: 12466402
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Use of mucin and hemoglobin in experimental murine gram-negative bacteremia enhances the immunoprotective action of antibodies reactive with the lipopolysaccharide core region.
    Appelmelk BJ; Verwey-van Vught AM; Maaskant JJ; Schouten WF; Thijs LG; Maclaren DM
    Antonie Van Leeuwenhoek; 1986; 52(6):537-42. PubMed ID: 3545072
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antiserum against Escherichia coli J5: a re-evaluation of its in vitro and in vivo activity against heterologous gram-negative bacteria.
    Trautmann M; Hahn H
    Infection; 1985; 13(3):140-5. PubMed ID: 3897069
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antibody responses to Escherichia coli J5 lipopolysaccharide and to Salmonella porin in patients with bacteremia.
    Brauner A; Källenius G; Wrangsell G; Wretlind B; Svenson SB
    Microb Pathog; 1986 Oct; 1(5):475-81. PubMed ID: 2854603
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Preparation of monospecific anti-Salmonella LPS antibodies from bacteria immobilized in polyacrylamide gel].
    Goichot J; Duphot M
    Ann Immunol (Paris); 1982; 133C(3):383-6. PubMed ID: 6756283
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antigenic homology among gram-negative organisms isolated from cattle with clinical mastitis.
    Tyler J; Spears H; Cullor J; Smith W; Nelson R; Martin J
    J Dairy Sci; 1991 Apr; 74(4):1235-42. PubMed ID: 1907303
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of SEF14 fimbrial dot blot and flagellar western blot tests as indicators of Salmonella enteritidis infection in chickens.
    Cooper GL; Thorns CJ
    Vet Rec; 1996 Feb; 138(7):149-53. PubMed ID: 8677603
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serological relationships between Escherichia coli and Salmonella smooth- and rough-mutant lipopolysaccharides as revealed by enzyme-linked immunosorbent assay for human immunoglobulin G antiendotoxin antibodies.
    Barclay GR; Scott BB
    Infect Immun; 1987 Nov; 55(11):2706-14. PubMed ID: 3312008
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of lipopolysaccharide and complement in susceptibility of Escherichia coli and Salmonella typhimurium to non-immune serum.
    Tomás JM; Ciurana B; Benedí VJ; Juarez A
    J Gen Microbiol; 1988 Apr; 134(4):1009-16. PubMed ID: 3053980
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The serological relationship between Yersinia enterocolitica O9 and Escherichia coli O157 using sera from patients with yersiniosis and haemolytic uraemic syndrome.
    Chart H; Cheasty T; Cope D; Gross RJ; Rowe B
    Epidemiol Infect; 1991 Oct; 107(2):349-56. PubMed ID: 1936156
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A noncovalent complex vaccine prepared with detoxified Escherichia coli J5 (Rc chemotype) lipopolysaccharide and Neisseria meningitidis Group B outer membrane protein produces protective antibodies against gram-negative bacteremia.
    Bhattacharjee AK; Opal SM; Taylor R; Naso R; Semenuk M; Zollinger WD; Moran EE; Young L; Hammack C; Sadoff JC; Cross AS
    J Infect Dis; 1996 May; 173(5):1157-63. PubMed ID: 8627067
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cross-reactivity between six Enterobacteriaceae complete lipopolysaccharide core chemotypes.
    Nnalue NA; Khan GN; Mustafa N
    J Med Microbiol; 1999 May; 48(5):433-441. PubMed ID: 10229540
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunization with rough mutants of Salmonella minnesota. IV. Protection by antisera to O and rough antigens against endotoxin.
    Johns M; Skehill A; McCabe WR
    J Infect Dis; 1983 Jan; 147(1):57-67. PubMed ID: 6185599
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of the opsonic capacity of core lipopolysaccharide antiserum of equine origin against smooth Escherichia coli 0111:B4, using macrophage chemiluminescence.
    Morris DD; Harmon BG; Moore JN
    Am J Vet Res; 1989 Aug; 50(8):1272-8. PubMed ID: 2675693
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Epitope specificities of murine monoclonal and rabbit polyclonal antibodies against enterobacterial lipopolysaccharides of the Re chemotype.
    Rozalski A; Brade L; Kosma P; Appelmelk BJ; Krogmann C; Brade H
    Infect Immun; 1989 Sep; 57(9):2645-52. PubMed ID: 2474499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.